Aida PharmaceuticalsAida Pharmaceuticals is a product-focused pharmaceuticals company engaged in the formulation, clinical testing, registration, manufacture, sales and marketing of advanced pharmaceutical and genetic products in mainland China. The Company's mission is to discover, develop and market meaningful new therapies that improve human health. Aida, in operation since March 1999, is headquartered in Hangzhou, China with manufacturing, distribution and sales points throughout mainland China. Aida is GMP certified in China and ISO9002 certified for quality assurance and ISO14000 certified for ecologically-friendly practices. Aida is now producing and marketing a patented prescription drug in China, etimicin sulfate. It is the first antibiotic developed in China and is regarded as a category "A" drug by the State Food and Drug Administration of China.
Aida Pharmaceuticals SEC Filings
Transfer Agent:
OTC Stock Transfer
231 E. 2100 South
Salt Lake City UT 84165
Phone: (801)485-5555
| Aida Pharmaceuticals Contact Info | EPG Contact Info | ||
|---|---|---|---|
| Name | Aida Pharmaceuticals Inc. | Name | Gary Geraci |
| Address | 31 Dingjiang Road | Title | President |
| Address 2 | Jianggan District | Telephone | 617.242.1025 |
| State, Country | Hangzhou, China 310016 | Fax | 617.242.2155 |
| IR@aidapharma.com | gary@equityperfgp.com | ||
| Website | AidaPharma.com | Website | EquityPerformanceGroup.com |
Keep your finger on the pulse of the market and receive immediate access to developments at all of EPG’s publicly traded clients by visiting our Request More Information page. There, you will be able to sign-up for company updates, to receive real time announcements, breaking news, media alerts, and information on upcoming client road shows, conferences and investor calls. You can also subscribe to EPG’s complementary monthly Client Update.